Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Rapeport

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|September 29, 2021
SARS-CoV-2 Human Challenge Studies. ReplyGarth Rapeport, Christopher Chiu, Helen McShane
Clinical and Translational Allergy|December 9, 2020
The role of antifungals in the management of patients with severe asthmaW Garth Rapeport, Kazuhiro Ito, David W Denning
American Journal of Respiratory and Critical Care Medicine|February 22, 2022
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are PreventableWilliam Cookson, Miriam Moffatt, Garth Rapeport, et al.
Drug Discovery Today|May 19, 2018
Current approaches to the discovery of novel inhaled medicinesPeter Strong, Kazuhiro Ito, John Murray, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and miceJonathan Baker, Hugo Ombredane, Leah Daly, et al.
The New England Journal of Medicine|July 21, 2021
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving PandemicGarth Rapeport, Emma Smith, Anthony Gilbert, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vivo</i> Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised MiceGenki Kimura, Takahiro Nakaoki, Thomas Colley, et al.
Mycoses|July 13, 2017
Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised miceGenki Kimura, Takahiro Nakaoki, Yuki Nishimoto, et al.
Neuroimage|August 31, 2002
Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanilRichard G Wise, Richard Rogers, Deborah Painter, et al.
Scientific Reports|July 3, 2019
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infectionThomas Colley, Gurpreet Sehra, Leah Daly, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|September 29, 2021
SARS-CoV-2 Human Challenge Studies. ReplyGarth Rapeport, Christopher Chiu, Helen McShane
Clinical and Translational Allergy|December 9, 2020
The role of antifungals in the management of patients with severe asthmaW Garth Rapeport, Kazuhiro Ito, David W Denning
American Journal of Respiratory and Critical Care Medicine|February 22, 2022
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are PreventableWilliam Cookson, Miriam Moffatt, Garth Rapeport, et al.
Drug Discovery Today|May 19, 2018
Current approaches to the discovery of novel inhaled medicinesPeter Strong, Kazuhiro Ito, John Murray, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and miceJonathan Baker, Hugo Ombredane, Leah Daly, et al.
The New England Journal of Medicine|July 21, 2021
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving PandemicGarth Rapeport, Emma Smith, Anthony Gilbert, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vivo</i> Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised MiceGenki Kimura, Takahiro Nakaoki, Thomas Colley, et al.
Mycoses|July 13, 2017
Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised miceGenki Kimura, Takahiro Nakaoki, Yuki Nishimoto, et al.
Neuroimage|August 31, 2002
Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanilRichard G Wise, Richard Rogers, Deborah Painter, et al.
Scientific Reports|July 3, 2019
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infectionThomas Colley, Gurpreet Sehra, Leah Daly, et al.
Pageof 3